Hisamitsu Pharmaceutical Co Inc

NEW
FSE:4530 (Japan)   Ordinary Shares
円 3,975 (0%) Jun 26
14.80
P/B:
0.96
Market Cap:
円 425.23B ($ 2.66B)
Enterprise V:
円 311.84B ($ 1.95B)
Volume:
0
Avg Vol (2M):
0
Trade In:

Business Description

Hisamitsu Pharmaceutical Co Inc

ISIN : JP3784600003

Share Class Description:

FSE:4530: Ordinary Shares

Total Employee Number:

3,697
Description
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
Name Current Vs Industry Vs History
Cash-To-Debt
49.95
Equity-to-Asset
0.8
Debt-to-Equity
0.01
Debt-to-EBITDA
0.08
Interest Coverage
853.24
Piotroski F-Score
6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
5.74
Distress
Grey
Safe
Beneish M-Score
-2.21
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
12-1 Month Momentum %
-5.69

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
4.08
Quick Ratio
3.57
Cash Ratio
2.35
Days Inventory
135.33
Days Sales Outstanding
111.5
Days Payable
57.12

Dividend & Buy Back

Name Current Vs Industry Vs History
Dividend Payout Ratio
0.17
3-Year Dividend Growth Rate
-18.8
3-Year Average Share Buyback Ratio
3.3
Shareholder Yield %
-0.23

Financials

FSE:4530's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Hisamitsu Pharmaceutical Co Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil 円) 163,024
EPS (TTM) (円) 268.56
Beta -0.0277
3-Year Sharpe Ratio 0.17
3-Year Sortino Ratio 0.46
Volatility % 6.02
14-Day RSI -
14-Day ATR (円) 0.000007
20-Day SMA (円) 3975
12-1 Month Momentum % -5.69
52-Week Range (円) 3975 - 4215
Shares Outstanding (Mil) 70.4

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Hisamitsu Pharmaceutical Co Inc Filings

Filing Date Document Date Form
No Filing Data

Hisamitsu Pharmaceutical Co Inc Stock Events

Financials Calendars
Event Date Price (円)
0.0000000426:1 Stock Split 2026-05-11 3,975.00 (+0.00%)
JPY 15.000000 Cash Dividend 2025-08-28 3,975.00 (+0.00%)
JPY 45.000000 Cash Dividend 2025-08-28 3,975.00 (+0.00%)
JPY 2.000000 Cash Dividend 2025-02-27 4,215.00 (+0.00%)
JPY 43.000000 Cash Dividend 2025-02-27 4,215.00 (+0.00%)
JPY 2.000000 Cash Dividend 2024-08-29 4,215.00 (+0.00%)
JPY 43.000000 Cash Dividend 2024-08-29 4,215.00 (+0.00%)
Show
Entries

Hisamitsu Pharmaceutical Co Inc Frequently Asked Questions

What is Hisamitsu Pharmaceutical Co Inc(FSE:4530)'s stock price today?
The current price of FSE:4530 is 円3975.00. The 52 week high of FSE:4530 is 円4215.00 and 52 week low is 円3975.00.
When is next earnings date of Hisamitsu Pharmaceutical Co Inc(FSE:4530)?
The next earnings date of Hisamitsu Pharmaceutical Co Inc(FSE:4530) is .
Does Hisamitsu Pharmaceutical Co Inc(FSE:4530) pay dividends? If so, how much?
Hisamitsu Pharmaceutical Co Inc(FSE:4530) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Hisamitsu Pharmaceutical Co Inc

No articles.